Recombinant COVID-19 vaccine based on recombinant RBD/Nucleoprotein and saponin adjuvant induces long-lasting neutralizing antibodies and cellular immunity.
基于重组 RBD/核蛋白和皂苷佐剂的重组 COVID-19 疫苗可诱导持久的中和抗体和细胞免疫
期刊:Frontiers in Immunology
影响因子:5.9
doi:10.3389/fimmu.2022.974364
Ghaemi Amir, Roshani Asl Parisa, Zargaran Hedieh, Ahmadi Delaram, Hashimi Asim Ali, Abdolalipour Elahe, Bathaeian Sahar, Miri Seyed Mohammad
